NAS:HSDT (USA)
Â
Class A
$
0.40
-0.010 (-2.44%)
03:50 PM EST
What is a stock summary page? Click here for an overview.
Business Description
Helius Medical Technologies Inc
NAICS : 325413
SIC : 3842
ISIN : US42328V5049
Share Class Description:
HSDT: Class ADescription
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 90.67 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -77.65 | |||||
| Beneish M-Score | -8.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -73.8 | |||||
| 3-Year EBITDA Growth Rate | 75.9 | |||||
| 3-Year EPS without NRI Growth Rate | 76.1 | |||||
| 3-Year FCF Growth Rate | 75.4 | |||||
| 3-Year Book Growth Rate | -87.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 293.75 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.29 | |||||
| 9-Day RSI | 45.39 | |||||
| 14-Day RSI | 43.29 | |||||
| 3-1 Month Momentum % | -32.59 | |||||
| 6-1 Month Momentum % | -10.58 | |||||
| 12-1 Month Momentum % | -91.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.08 | |||||
| Cash Ratio | 0.5 | |||||
| Days Inventory | 609.84 | |||||
| Days Sales Outstanding | 53.63 | |||||
| Days Payable | 532.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -266.1 | |||||
| Shareholder Yield % | -125.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -11.92 | |||||
| Operating Margin % | -2665.96 | |||||
| Net Margin % | -2258.08 | |||||
| FCF Margin % | -2124.23 | |||||
| ROE % | -377.97 | |||||
| ROA % | -186.84 | |||||
| ROIC % | -1214.56 | |||||
| 3-Year ROIIC % | -285.08 | |||||
| ROC (Joel Greenblatt) % | -7397.55 | |||||
| ROCE % | -311.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.4 | |||||
| PB Ratio | 1.43 | |||||
| Price-to-Tangible-Book | 1.43 | |||||
| EV-to-EBIT | -0.09 | |||||
| EV-to-EBITDA | -0.09 | |||||
| EV-to-Revenue | 2.4 | |||||
| EV-to-Forward-Revenue | 0.03 | |||||
| EV-to-FCF | -0.11 | |||||
| Price-to-GF-Value | 0.53 | |||||
| Price-to-Net-Current-Asset-Value | 1.6 | |||||
| Earnings Yield (Greenblatt) % | -1111.11 | |||||
| FCF Yield % | -486.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSDT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Helius Medical Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.52 | ||
| EPS (TTM) ($) | -5.73 | ||
| Beta | 0.91 | ||
| 3-Year Sharpe Ratio | -1.65 | ||
| 3-Year Sortino Ratio | -1.69 | ||
| Volatility % | 92.07 | ||
| 14-Day RSI | 43.29 | ||
| 14-Day ATR ($) | 0.04749 | ||
| 20-Day SMA ($) | 0.417108 | ||
| 12-1 Month Momentum % | -91.63 | ||
| 52-Week Range ($) | 0.373 - 7.188 | ||
| Shares Outstanding (Mil) | 5.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Helius Medical Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Helius Medical Technologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Helius Medical Technologies Inc Frequently Asked Questions
What is Helius Medical Technologies Inc(HSDT)'s stock price today?
The current price of HSDT is $0.40. The 52 week high of HSDT is $7.19 and 52 week low is $0.37.
When is next earnings date of Helius Medical Technologies Inc(HSDT)?
The next earnings date of Helius Medical Technologies Inc(HSDT) is 2025-05-13 Est..
Does Helius Medical Technologies Inc(HSDT) pay dividends? If so, how much?
Helius Medical Technologies Inc(HSDT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers